Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ING2 | Q9H160 | 1/20 | 0.46 |
| ▸ | DUSP5 | Q16690 | 1/20 | 0.42 |
| ▸ | DUSP6 | Q16828 | 1/20 | 0.42 |
| ▸ | PTPRB | P23467 | 1/20 | 0.41 |
| ▸ | CD69 | Q07108 | 1/20 | 0.35 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.32 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.32 |
| ▸ | PTPN4 | P29074 | 1/20 | 0.32 |
| ▸ | PTPN9 | P43378 | 1/20 | 0.32 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | DRD2 | P14416 | 1/20 | 0.30 |
| ▸ | DRD1 | P21728 | 1/20 | 0.30 |
| ▸ | DRD5 | P21918 | 1/20 | 0.30 |
| ▸ | DRD3 | P35462 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29617578 | 0.71 | ING2 (0.35) | ING2DUSP5DUSP6PTPRBCYP3A4 | |
| SCHEMBL15076044 | 0.71 | ING2 (0.35) | ING2DUSP5DUSP6PTPRBCYP3A4 | |
| SCHEMBL2995695 | 0.71 | CYP3A4 (0.48) | ING2DUSP5DUSP6PTPRBCD69 | |
| SCHEMBL13287042 | 0.71 | SELL (0.48) | ING2DUSP5DUSP6PTPRBCD69 | |
| SCHEMBL30525542 | 0.67 | FYN (0.48) | ING2CYP3A4MAPTDRD2DRD1 | |
| SCHEMBL29441859 | 0.67 | FYN (0.41) | ING2DUSP5DUSP6PTPRBCYP3A4 | |
| SCHEMBL7777089 | 0.67 | FYN (0.48) | ING2CYP3A4MAPTDRD2DRD1 | |
| SCHEMBL14848401 | 0.66 | ING2 (0.46) | ING2DUSP5DUSP6PTPRBCD69 | |
| SCHEMBL30547266 | 0.66 | GABRA1 (0.50) | ING2DUSP5DUSP6PTPRBCD69 | |
| SCHEMBL2471228 | 0.66 | GABRA1 (0.50) | ING2DUSP5DUSP6PTPRBCD69 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240208921-A1 | Synthesis of Thiophene Derivatized Polyphenolic Calixarenes | UNIVERSITY OF CINCINNATI (US) | 2024-06-27 | — | — | US | claimed |
| US-11815431-B2 | Electrical gas detector comprising an arene-functionalized nanowire | UNIVERSITY OF SURREY | 2023-11-14 | — | — | US | claimed |
| EP-3548882-B1 | FIELD-EFFECT-BASED GAS DETECTOR COMPRISING AN ARENE-FUNCTIONALIZED NANOWIRE AN ARENE-FUNCTIONALIZED NANOWIRE | UNIV SURREY (GB) | 2023-09-13 | — | — | EP | claimed |
| US-20230168203-A9 | Pyrogallarene Chelating and Sequestering Agents | KINSEY SPIEL (US) | 2023-06-01 | — | — | US | claimed |
| US-20240208921-A1 | Synthesis of Thiophene Derivatized Polyphenolic Calixarenes | UNIVERSITY OF CINCINNATI (US) | 2024-06-27 | — | — | US | disclosed |
| US-11815431-B2 | Electrical gas detector comprising an arene-functionalized nanowire | UNIVERSITY OF SURREY | 2023-11-14 | — | — | US | disclosed |
| EP-3548882-B1 | FIELD-EFFECT-BASED GAS DETECTOR COMPRISING AN ARENE-FUNCTIONALIZED NANOWIRE AN ARENE-FUNCTIONALIZED NANOWIRE | UNIV SURREY (GB) | 2023-09-13 | — | — | EP | disclosed |
| US-20230168203-A9 | Pyrogallarene Chelating and Sequestering Agents | KINSEY SPIEL (US) | 2023-06-01 | — | — | US | disclosed |
| US-11629113-B2 | Pyrogallol[2]resorcin[2]arene | UNIVERSITY OF CINCINNATI (US) | 2023-04-18 | — | — | US | disclosed |
| US-20220135508-A1 | Pyrogallol[2]resorcin[2]arene | UNIVERSITY OF CINCINNATI (US) | 2022-05-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220135508-A1 | Pyrogallol[2]resorcin[2]arene | AGL, PGLS, MGAM | ING2 3946/4885DUSP5 2840/4885DUSP6 1617/4885 |
| US-11629113-B2 | Pyrogallol[2]resorcin[2]arene | AGL, PGLS, MGAM | ING2 3946/4885DUSP5 2840/4885DUSP6 1617/4885 |
| US-20240208921-A1 | Synthesis of Thiophene Derivatized Polyphenolic Calixarenes | LGALS4, CALD1, CALU | ING2 2349/4885DUSP5 1752/4885DUSP6 1588/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.